Tesla CEO Elon Musk dismissed inquiries regarding allegations of drug use and personal controversies during a recent press event, where President Donald Trump was present. Reporters attempted to ask Musk about a detailed report citing his consumption of substances such as ketamine, Ecstasy, and psychedelic mushrooms during Trump’s 2024 presidential campaign.
During the exchange, Musk interrupted the questioning, challenging the credibility of the publication that released the report by referencing past controversies involving the same outlet. He emphasized past judicial rulings against the publication for supposed inaccuracies connected to reports on election interference.
Musk has been an active supporter of President Trump’s bid for a second term, contributing over $250 million and leading initiatives aimed at reducing federal expenditure and downsizing government workforce. Despite the allegations, a White House spokesperson acknowledged Musk's role in governmental efficiency efforts but declined to comment on the drug use claims.
At this time, the details of the report have not been independently verified by other sources. Both Musk and the White House have not provided further comments. This situation remains under close observation as more information becomes available.
